Biomarkers of ovarian reserve-do they predict somatic aging?

Seminars in Reproductive Medicine

Volumn 31, Issue 6, 2013, Pages 443-451

  Cedars, Marcelle I ^a  

^a Women's Hlth Clin Research Center   (United States)

Author keywords

mitochondrial function and aging; ovarian aging; oxidative stress; somatic aging

Indexed keywords

BIOLOGICAL MARKER;

AGING; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLIMACTERIUM; COGNITION; DEMENTIA; DEPRESSION; GENE MUTATION; GENETIC MANIPULATION; HEALTH HAZARD; HUMAN; MENOPAUSE; MOOD CHANGE; OSTEOLYSIS; OVARIAN RESERVE; OVARY FUNCTION; PREDICTION; SLEEP DISORDER; TELOMERE; ADULT; ANIMAL; EARLY MENOPAUSE; EVIDENCE BASED MEDICINE; FEMALE; GROWTH, DEVELOPMENT AND AGING; METABOLISM; OOCYTE DEVELOPMENT; OVARY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AGING; ANIMALS; BIOLOGICAL MARKERS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MENOPAUSE, PREMATURE; OOGENESIS; OVARY;

EID: 84885359434     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0033-1356480     Document Type: Article

References (152)

1. van Rooij I. A., Tonkelaar Id, Broekmans F. J., et al. Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause: 2004; 11 6, Pt 1 601 606 (Pubitemid 40353222)
2. Broekmans F. J., Faddy M. J., Scheffer G., te Velde E. R. Antral follicle counts are related to age at natural fertility loss and age at menopause. Menopause: 2004; 11 6, Pt 1 607 614 (Pubitemid 40353223)
3. Broer S. L., Eijkemans M. J., Scheffer G. J., et al. Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab: 2011; 96 8 2532 2539
4. Tehrani F. R., Solaymani-Dodaran M., Tohidi M., Gohari M. R., Azizi F. Modeling age at menopause using serum concentration of anti-mullerian hormone. J Clin Endocrinol Metab: 2013; 98 2 729 735
5. Freeman E. W., Sammel M. D., Lin H., Gracia C. R. Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol Metab: 2012; 97 5 1673 1680
6. Wellons M. F., Bates G. W., Schreiner P. J., Siscovick D. S., Sternfeld B., Lewis C. E. Antral follicle count predicts natural menopause in a population-based sample: the Coronary Artery Risk Development in Young Adults Women's Study. Menopause: 2013; 20 8 825 830
7. Snowdon D. A., Kane R. L., Beeson W. L., et al. Is early natural menopause a biologic marker of health and aging? Am J Public Health: 1989; 79 6 709 714 (Pubitemid 19142908)
8. Cooper G. S., Sandler D. P. Age at natural menopause and mortality. Ann Epidemiol: 1998; 8 4 229 235 (Pubitemid 28208940)
9. Cooper G. S., Baird D. D., Weinberg C. R., Ephross S. A., Sandler D. P. Age at menopause and childbearing patterns in relation to mortality. Am J Epidemiol: 2000; 151 6 620 623 (Pubitemid 30463607)
10. Jansen S. C., Temme E. H., Schouten E. G. Lifetime estrogen exposure versus age at menopause as mortality predictor. Maturitas: 2002; 43 2 105 112 (Pubitemid 35217769)
11. Jacobsen B. K., Heuch I., Kvåle G. Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women. Am J Epidemiol: 2003; 157 10 923 929 (Pubitemid 36555052)
12. Mondul A. M., Rodriguez C., Jacobs E. J., Calle E. E. Age at natural menopause and cause-specific mortality. Am J Epidemiol: 2005; 162 11 1089 1097 (Pubitemid 41746621)
13. Ossewaarde M. E., Bots M. L., Verbeek A. L., et al. Age at menopause, cause-specific mortality and total life expectancy. Epidemiology: 2005; 16 4 556 562 (Pubitemid 40847843)
14. Tom S. E., Cooper R., Wallace R. B., Guralnik J. M. Type and timing of menopause and later life mortality among women in the Iowa Established Populations for the Epidemiological Study of the Elderly (EPESE) cohort. J Womens Health (Larchmt): 2012; 21 1 10 16
15. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol: 1956; 11 3 298 300
16. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol: 1956; 11 3 298 300
17. Miquel J., Economos A. C., Fleming J., Johnson J. E. Jr. Mitochondrial role in cell aging. Exp Gerontol: 1980; 15 6 575 591 (Pubitemid 11243249)
18. Kotrschal A., Ilmonen P., Penn D. J. Stress impacts telomere dynamics. Biol Lett: 2007; 3 2 128 130 (Pubitemid 351878152)
19. Finkel T., Holbrook N. J. Oxidants, oxidative stress and the biology of ageing. Nature: 2000; 408 6809 239 247
20. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci: 2002; 27 7 339 344 (Pubitemid 34756516)
21. Haendeler J., Hoffmann J., Brandes R. P., Zeiher A. M., Dimmeler S. Hydrogen peroxide triggers nuclear export of telomerase reverse transcriptase via Src kinase family-dependent phosphorylation of tyrosine 707. Mol Cell Biol: 2003; 23 13 4598 4610 (Pubitemid 36734749)
22. Malinger G., Zakut H., Soreq H. Cholinoceptive properties of human primordial, preantral, and antral oocytes: in situ hybridization and biochemical evidence for expression of cholinesterase genes. J Mol Neurosci: 1989; 1 2 77 84
23. Singh B., Rutledge J. M., Armstrong D. T. Epidermal growth factor and its receptor gene expression and peptide localization in porcine ovarian follicles. Mol Reprod Dev: 1995; 40 4 391 399
24. Keefe D. MtDNA deletions on oocytes and reproductive aging in women. Fertil Steril: 1995; 64 3 577 583
25. Brenner C. A., Wolny Y. M., Barritt J. A., Matt D. W., Munné S., Cohen J. Mitochondrial DNA deletion in human oocytes and embryos. Mol Hum Reprod: 1998; 4 9 887 892 (Pubitemid 28430653)
26. Tarín J. J. Aetiology of age-associated aneuploidy: a mechanism based on the 'free radical theory of ageing'. Hum Reprod: 1995; 10 6 1563 1565
27. Phaneuf S., Leeuwenburgh C. Cytochrome c release from mitochondria in the aging heart: a possible mechanism for apoptosis with age. Am J Physiol Regul Integr Comp Physiol: 2002; 282 2 R423 R430 (Pubitemid 34664592)
28. Lodish H., Berk A., Zipursky L. S., et al. Cellular energetics: glycolysis, aerobic oxidation, and photosynthesis. In: Freeman W. H., ed. Molecular Cell Biology. 2000: http://www.ncbi.nlm.nih.gov/books/bv.fcgi? highlight=mitochondrial,function&rid=mcb.section.4377#4383
29. May-Panloup P., Chretien M. F., Malthiery Y., Reynier P. Mitochondrial DNA in the oocyte and the developing embryo. Curr Top Dev Biol: 2007; 77 51 83
30. Barritt J. A., Kokot M., Cohen J., Steuerwald N., Brenner C. A. Quantification of human ooplasmic mitochondria. Reprod Biomed Online: 2002; 4 3 243 247
31. Leese H. J., Barton A. M. Pyruvate and glucose uptake by mouse ova and preimplantation embryos. J Reprod Fertil: 1984; 72 1 9 13 (Pubitemid 14064048)
32. Fujino Y., Ozaki K., Yamamasu S., et al. DNA fragmentation of oocytes in aged mice. Hum Reprod: 1996; 11 7 1480 1483 (Pubitemid 26335097)
33. Perez G. I., Jurisicova A., Matikainen T., et al. A central role for ceramide in the age-related acceleration of apoptosis in the female germline. FASEB J: 2005; 19 7 860 862 (Pubitemid 40617409)
34. Eichenlaub-Ritter U., Vogt E., Yin H., Gosden R. Spindles, mitochondria and redox potential in ageing oocytes. Reprod Biomed Online: 2004; 8 1 45 58 (Pubitemid 38100688)
35. Blackburn E. H. Telomere states and cell fates. Nature: 2000; 408 6808 53 56
36. Blackburn E. H., Greider C. W., Szostak J. W. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med: 2006; 12 10 1133 1138 (Pubitemid 44527346)
37. Sitte N., Saretzki G., von Zglinicki T. Accelerated telomere shortening in fibroblasts after extended periods of confluency. Free Radic Biol Med: 1998; 24 6 885 893 (Pubitemid 28186228)
38. Kawanishi S., Oikawa S. Mechanism of telomere shortening by oxidative stress. Ann N Y Acad Sci: 2004; 1019 278 284 (Pubitemid 38951320)
39. Zhang P., Dilley C., Mattson M. P. DNA damage responses in neural cells: Focus on the telomere. Neuroscience: 2007; 145 4 1439 1448 (Pubitemid 46602741)
40. Hezel A. F., Bardeesy N., Maser R. S. Telomere induced senescence: end game signaling. Curr Mol Med: 2005; 5 2 145 152 (Pubitemid 40601642)
41. Aviv A. Telomeres and human aging: facts and fibs. Sci SAGE KE: 2004; 2004 51 pe43
42. Cawthon R. M., Smith K. R., O'Brien E., Sivatchenko A., Kerber R. A. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet: 2003; 361 9355 393 395 (Pubitemid 36164975)
43. Martin-Ruiz C., Dickinson H. O., Keys B., Rowan E., Kenny R. A., Von Zglinicki T. Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann Neurol: 2006; 60 2 174 180 (Pubitemid 44182392)
44. Beyne-Rauzy O., Prade-Houdellier N., Demur C., et al. Tumor necrosis factor-alpha inhibits hTERT gene expression in human myeloid normal and leukemic cells. Blood: 2005; 106 9 3200 3205 (Pubitemid 41565919)
45. Fu W., Lu C., Mattson M. P. Telomerase mediates the cell survival-promoting actions of brain-derived neurotrophic factor and secreted amyloid precursor protein in developing hippocampal neurons. J Neurosci: 2002; 22 24 10710 10719 (Pubitemid 36005145)
46. Gorbunova V., Seluanov A., Pereira-Smith O. M. Expression of human telomerase (hTERT) does not prevent stress-induced senescence in normal human fibroblasts but protects the cells from stress-induced apoptosis and necrosis. J Biol Chem: 2002; 277 41 38540 38549 (Pubitemid 35154713)
47. Mattson M. P., Fu W., Zhang P. Emerging roles for telomerase in regulating cell differentiation and survival: a neuroscientist's perspective. Mech Ageing Dev: 2001; 122 7 659 671 (Pubitemid 32378719)
48. Liu L., Trimarchi J. R., Smith P. J., Keefe D. L. Mitochondrial dysfunction leads to telomere attrition and genomic instability. Aging Cell: 2002; 1 1 40 46
49. Liu L., Franco S., Spyropoulos B., Moens P. B., Blasco M. A., Keefe D. L. Irregular telomeres impair meiotic synapsis and recombination in mice. Proc Natl Acad Sci U S A: 2004; 101 17 6496 6501 (Pubitemid 38586002)
50. Liu L., Trimarchi J. R., Navarro P., Blasco M. A., Keefe D. L. Oxidative stress contributes to arsenic-induced telomere attrition, chromosome instability, and apoptosis. J Biol Chem: 2003; 278 34 31998 32004 (Pubitemid 37051543)
51. Keefe D. L., Franco S., Liu L., et al. Telomere length predicts embryo fragmentation after in vitro fertilization in women-toward a telomere theory of reproductive aging in women. Am J Obstet Gynecol: 2005; 192 4 1256 1260, discussion 1260-1261
52. Butts S. F., Seifer D. B. Racial and ethnic differences in reproductive potential across the life cycle. Fertil Steril: 2010; 93 3 681 690
53. Sohal R. S., Orr W. C. The redox stress hypothesis of aging. Free Radic Biol Med: 2012; 52 3 539 555
54. Soules M. R., Sherman S., Parrott E., et al. Stages of Reproductive Aging Workshop (STRAW). J Womens Health Gend Based Med: 2001; 10 9 843 848 (Pubitemid 33138765)
55. Lambalk C. B., van Disseldorp J., de Koning C. H., Broekmans F. J. Testing ovarian reserve to predict age at menopause. Maturitas: 2009; 63 4 280 291
56. Lawson R., El-Toukhy T., Kassab A., et al. Poor response to ovulation induction is a stronger predictor of early menopause than elevated basal FSH: a life table analysis. Hum Reprod: 2003; 18 3 527 533 (Pubitemid 36329319)
57. de Boer E. J., den Tonkelaar I., te Velde E. R., Burger C. W., Klip H., van Leeuwen F. E.; OMEGA-project group. A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause. Fertil Steril: 2002; 77 5 978 985 (Pubitemid 34497166)
58. van Disseldorp J., Faddy M. J., Themmen A. P., et al. Relationship of serum antimüllerian hormone concentration to age at menopause. J Clin Endocrinol Metab: 2008; 93 6 2129 2134 (Pubitemid 351831526)
59. Lisabeth L. D., Beiser A. S., Brown D. L., Murabito J. M., Kelly-Hayes M., Wolf P. A. Age at natural menopause and risk of ischemic stroke: the Framingham heart study. Stroke: 2009; 40 4 1044 1049
60. Shuster L. T., Rhodes D. J., Gostout B. S., Grossardt B. R., Rocca W. A. Premature menopause or early menopause: long-term health consequences. Maturitas: 2010; 65 2 161 166
61. Feng Y., Hong X. M., Wilker E., et al. Effects of age at menarche, reproductive years, and menopause on metabolic risk factors for cardiovascular diseases. Atherosclerosis: 2008; 196 2 590 597
62. Parashar S., Reid K. J., Spertus J. A., Shaw L. J., Vaccarino V. Early menopause predicts angina after myocardial infarction. Menopause: 2010; 17 5 938 945
63. Colditz G. A., Willett W. C., Stampfer M. J., Rosner B., Speizer F. E., Hennekens C. H. Menopause and the risk of coronary heart disease in women. N Engl J Med: 1987; 316 18 1105 1110 (Pubitemid 17052498)
64. Park H. T., Cho G. J., Ahn K. H., et al. Association of insulin resistance with anti-Mullerian hormone levels in women without polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf): 2010; 72 1 26 31
65. Jacobsen B. K., Nilssen S., Heuch I., Kvåle G. Does age at natural menopause affect mortality from ischemic heart disease? J Clin Epidemiol: 1997; 50 4 475 479 (Pubitemid 27223277)
66. van der Schouw Y. T., van der Graaf Y., Steyerberg E. W., Eijkemans J. C., Banga J. D. Age at menopause as a risk factor for cardiovascular mortality. Lancet: 1996; 347 9003 714 718 (Pubitemid 26085645)
67. Roy S. K., Terada D. M. Activities of glucose metabolic enzymes in human preantral follicles: in vitro modulation by follicle-stimulating hormone, luteinizing hormone, epidermal growth factor, insulin-like growth factor I, and transforming growth factor beta1. Biol Reprod: 1999; 60 3 763 768 (Pubitemid 29102412)
68. Palmer J. R., Rosenberg L., Shapiro S. Reproductive factors and risk of myocardial infarction. Am J Epidemiol: 1992; 136 4 408 416
69. Fioretti F., Tavani A., Gallus S., Franceschi S., La Vecchia C. Menopause and risk of non-fatal acute myocardial infarction: an Italian case-control study and a review of the literature. Hum Reprod: 2000; 15 3 599 603 (Pubitemid 30142368)
70. Lin J. W., Caffrey J. L., Chang M. H., Lin Y. S. Sex, menopause, metabolic syndrome, and all-cause and cause-specific mortality-cohort analysis from the Third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab: 2010; 95 9 4258 4267
71. de Kleijn M. J., van der Schouw Y. T., van der Graaf Y. Reproductive history and cardiovascular disease risk in postmenopausal women: a review of the literature. Maturitas: 1999; 33 1 7 36 (Pubitemid 29469716)
72. Atsma F., Bartelink M. L., Grobbee D. E., van der Schouw Y. T. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause: 2006; 13 2 265 279
73. Cui R., Iso H., Toyoshima H., et al. JACC Study Group. Relationships of age at menarche and menopause, and reproductive year with mortality from cardiovascular disease in Japanese postmenopausal women: the JACC study. J Epidemiol: 2006; 16 5 177 184 (Pubitemid 44574682)
74. Joakimsen O., Bonaa K. H., Stensland-Bugge E., Jacobsen B. K. Population-based study of age at menopause and ultrasound assessed carotid atherosclerosis: The Tromso Study. J Clin Epidemiol: 2000; 53 5 525 530 (Pubitemid 30254350)
75. Jacobsen B. K., Knutsen S. F., Fraser G. E. Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist Health Study. J Clin Epidemiol: 1999; 52 4 303 307 (Pubitemid 29305302)
76. Matthews K. A., Santoro N., Lasley B., et al. Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle characteristics and reproductive hormones in the follicular and luteal phases. J Clin Endocrinol Metab: 2006; 91 5 1789 1795
77. Gorgels W. J., v d Graaf Y, Blankenstein M. A., Collette H. J., Erkelens D. W., Banga J. D. Urinary sex hormone excretions in premenopausal women and coronary heart disease risk: a nested case-referent study in the DOM-cohort. J Clin Epidemiol: 1997; 50 3 275 281 (Pubitemid 27165704)
78. Solomon C. G., Hu F. B., Dunaif A., et al. Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab: 2002; 87 5 2013 2017 (Pubitemid 34521483)
79. Punnonen R., Jokela H., Aine R., Teisala K., Salomäki A., Uppa H. Impaired ovarian function and risk factors for atherosclerosis in premenopausal women. Maturitas: 1997; 27 3 231 238 (Pubitemid 27356255)
80. Bairey Merz C. N., Johnson B. D., Sharaf B. L., et al. WISE Study Group. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol: 2003; 41 3 413 419 (Pubitemid 36164495)
81. Gast G. C., Grobbee D. E., Smit H. A., Bueno-de-Mesquita H. B., Samsioe G. N., van der Schouw Y. T. Menstrual cycle characteristics and risk of coronary heart disease and type 2 diabetes. Fertil Steril: 2010; 94 6 2379 2381
82. Nelson L. M. Clinical practice. Primary ovarian insufficiency. N Engl J Med: 2009; 360 6 606 614
83. De Vos M., Devroey P., Fauser B. C. Primary ovarian insufficiency. Lancet: 2010; 376 9744 911 921
84. Kalantaridou S. N., Naka K. K., Papanikolaou E., et al. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab: 2004; 89 8 3907 3913 (Pubitemid 39071493)
85. Clarkson T. B. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression. Menopause: 2007; 14 3, Pt 1 373 384
86. Sanders J. L., Newman A. B. Telomere Length in Epidemiology: A Biomarker of Aging, Age-Related Disease, Both, or Neither? Epidemiol Rev: 2013; Jan 9
87. Sobenin I. A., Chistiakov D. A., Bobryshev Y. V., Postnov A. Y., Orekhov A. N. Mitochondrial Mutations in Atherosclerosis: New Solutions in Research and Possible Clinical Applications. Curr Pharm Des: 2013; Feb 15
88. Li X., Fang P., Mai J., Choi E. T., Wang H., Yang X. F. Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers. J Hematol Oncol: 2013; 6 19
89. Fyhrquist F., Saijonmaa O. Telomere length and cardiovascular aging. Ann Med: 2012; 44 01 S138 S142
90. Huzen J., de Boer R. A., van Veldhuisen D. J., van Gilst W. H., van der Harst P. The emerging role of telomere biology in cardiovascular disease. Front Biosci (Landmark Ed): 2010; 15 35 45
91. De Meyer T., Rietzschel E. R., De Buyzere M. L., Van Criekinge W., Bekaert S. Telomere length and cardiovascular aging: the means to the ends? Ageing Res Rev: 2011; 10 2 297 303
92. Pal L., Zhang K., Zeitlian G., Santoro N. Characterizing the reproductive hormone milieu in infertile women with diminished ovarian reserve. Fertil Steril: 2010; 93 4 1074 1079
93. Mersereau J. E., Evans M. L., Moore D. H., et al. Luteal phase estrogen is decreased in regularly menstruating older women compared with a reference population of younger women. Menopause: 2008; 15 3 482 486 (Pubitemid 351656753)
94. Matthews K. A., Crawford S. L., Chae C. U., et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol: 2009; 54 25 2366 2373
95. Matthews K. A., Kuller L. H., Chang Y., Edmundowicz D. Premenopausal risk factors for coronary and aortic calcification: a 20-year follow-up in the healthy women study. Prev Med: 2007; 45 4 302 308 (Pubitemid 47562534)
96. Kuller L. H., Matthews K. A., Sutton-Tyrrell K., Edmundowicz D., Bunker C. H. Coronary and aortic calcification among women 8 years after menopause and their premenopausal risk factors: the healthy women study. Arterioscler Thromb Vasc Biol: 1999; 19 9 2189 2198 (Pubitemid 29422252)
97. Lee J. S., Hayashi K., Mishra G., Yasui T., Kubota T., Mizunuma H. Independent association between age at natural menopause and hypercholesterolemia, hypertension, and diabetes mellitus: Japan nurses' health study. J Atheroscler Thromb: 2013; 20 2 161 169
98. Wellons M., Ouyang P., Schreiner P. J., Herrington D. M., Vaidya D. Early menopause predicts future coronary heart disease and stroke: the Multi-Ethnic Study of Atherosclerosis. Menopause: 2012; 19 10 1081 1087
99. Jacobsen B. K., Knutsen S. F., Fraser G. E. Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist Health Study. J Clin Epidemiol: 1999; 52 4 303 307 (Pubitemid 29305302)
100. Hu F. B., Grodstein F., Hennekens C. H., et al. Age at natural menopause and risk of cardiovascular disease. Arch Intern Med: 1999; 159 10 1061 1066 (Pubitemid 29230857)
101. Lokkegaard E., Jovanovic Z., Heitmann B. L., Keiding N., Ottesen B., Pedersen A. T. The association between early menopause and risk of ischaemic heart disease: influence of Hormone Therapy. Maturitas: 2006; 53 2 226 233 (Pubitemid 41820516)
102. Baba Y., Ishikawa S., Amagi Y., Kayaba K., Gotoh T., Kajii E. Premature menopause is associated with increased risk of cerebral infarction in Japanese women. Menopause: 2010; 17 3 506 510
103. Cramer D. W., Xu H., Harlow B. L. Family history as a predictor of early menopause. Fertil Steril: 1995; 64 4 740 745
104. Torgerson D. J., Thomas R. E., Reid D. M. Mothers and daughters menopausal ages: is there a link? Eur J Obstet Gynecol Reprod Biol: 1997; 74 1 63 66 (Pubitemid 27272185)
105. van Asselt K. M., Kok H. S., Pearson P. L., et al. Heritability of menopausal age in mothers and daughters. Fertil Steril: 2004; 82 5 1348 1351 (Pubitemid 39469459)
106. Mishra G., Hardy R., Kuh D. Are the effects of risk factors for timing of menopause modified by age? Results from a British birth cohort study. Menopause: 2007; 14 4 717 724 (Pubitemid 47051966)
107. Kok H. S., van Asselt K. M., van der Schouw Y. T., et al. Heart disease risk determines menopausal age rather than the reverse. J Am Coll Cardiol: 2006; 47 10 1976 1983
108. Lloyd-Jones D. M., Leip E. P., Larson M. G., et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation: 2006; 113 6 791 798
109. Berry J. D., Liu K., Folsom A. R., et al. Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis. Circulation: 2009; 119 3 382 389
110. Berry J. D., Dyer A., Cai X., et al. Lifetime risks of cardiovascular disease. N Engl J Med: 2012; 366 4 321 329
111. Chu M. C., Rath K. M., Huie J., Taylor H. S. Elevated basal FSH in normal cycling women is associated with unfavourable lipid levels and increased cardiovascular risk. Hum Reprod: 2003; 18 8 1570 1573 (Pubitemid 36958032)
112. Pal L., Bevilacqua K., Zeitlian G., Shu J., Santoro N. Implications of diminished ovarian reserve (DOR) extend well beyond reproductive concerns. Menopause: 2008; 15 6 1086 1094
113. Pal L., Norian J., Zeitlian G., Bevilacqua K., Freeman R., Santoro N. Vasomotor symptoms in infertile premenopausal women: a hitherto unappreciated risk for low bone mineral density. Fertil Steril: 2008; 90 5 1626 1634
114. Wu Z., Boss O. Targeting PGC-1 alpha to control energy homeostasis. Expert Opin Ther Targets: 2007; 11 10 1329 1338 (Pubitemid 47604072)
115. Sun L., Zhang Z., Zhu L. L., et al. Further evidence for direct pro-resorptive actions of FSH. Biochem Biophys Res Commun: 2010; 394 1 6 11
116. Robinson L. J., Tourkova I., Wang Y., et al. FSH-receptor isoforms and FSH-dependent gene transcription in human monocytes and osteoclasts. Biochem Biophys Res Commun: 2010; 394 1 12 17
117. Zhu L. L., Blair H., Cao J., et al. Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis. Proc Natl Acad Sci U S A: 2012; 109 36 14574 14579
118. Geng W., Yan X., Du H., Cui J., Li L., Chen F. Immunization with FSHβ fusion protein antigen prevents bone loss in a rat ovariectomy-induced osteoporosis model. Biochem Biophys Res Commun: 2013; 434 2 280 286
119. Soares C. N., Maki P. M. Menopausal transition, mood, and cognition: an integrated view to close the gaps. Menopause: 2010; 17 4 812 814
120. Boulware M. I., Kent B. A., Frick K. M. The impact of age-related ovarian hormone loss on cognitive and neural function. Curr Top Behav Neurosci: 2012; 10 165 184
121. Maki P. M., Freeman E. W., Greendale G. A., et al. Summary of the National Institute on Aging-sponsored conference on depressive symptoms and cognitive complaints in the menopausal transition. Menopause: 2010; 17 4 815 822
122. Barron A. M., Pike C. J. Sex hormones, aging, and Alzheimer's disease. Front Biosci (Elite Ed): 2012; 4 976 997
123. Henderson V. W., Brinton R. D. Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy. Prog Brain Res: 2010; 182 77 96
124. Grimm A., Lim Y. A., Mensah-Nyagan A. G., Götz J., Eckert A. Alzheimer's disease, oestrogen and mitochondria: an ambiguous relationship. Mol Neurobiol: 2012; 46 1 151 160
125. Yao J., Brinton R. D. Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease. Adv Pharmacol: 2012; 64 327 371
126. Long J., He P., Shen Y., Li R. New evidence of mitochondria dysfunction in the female Alzheimer's disease brain: deficiency of estrogen receptor-β J Alzheimers Dis: 2012; 30 3 545 558
127. Schupf N., Pang D., Patel B. N., et al. Onset of dementia is associated with age at menopause in women with Down's syndrome. Ann Neurol: 2003; 54 4 433 438 (Pubitemid 37176536)
128. Coppus A. M., Evenhuis H. M., Verberne G. J., et al. Early age at menopause is associated with increased risk of dementia and mortality in women with Down syndrome. J Alzheimers Dis: 2010; 19 2 545 550
129. Geerlings M. I., Ruitenberg A., Witteman J. C., et al. Reproductive period and risk of dementia in postmenopausal women. JAMA: 2001; 285 11 1475 1481 (Pubitemid 32221896)
130. Rocca W. A., Grossardt B. R., Shuster L. T. Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity. Brain Res: 2011; 1379 188 198
131. Amtul Z., Wang L., Westaway D., Rozmahel R. F. Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer's disease. Neuroscience: 2010; 169 2 781 786
132. Zhao L., Yao J., Mao Z., Chen S., Wang Y., Brinton R. D. 17β-Estradiol regulates insulin-degrading enzyme expression via an ERβ/PI3-K pathway in hippocampus: relevance to Alzheimer's prevention. Neurobiol Aging: 2011; 32 11 1949 1963
133. Whitmer R. A., Quesenberry C. P., Zhou J., Yaffe K. Timing of hormone therapy and dementia: the critical window theory revisited. Ann Neurol: 2011; 69 1 163 169
134. Sherwin B. B. Estrogen and cognitive functioning in women: lessons we have learned. Behav Neurosci: 2012; 126 1 123 127
135. Salpeter S. R., Buckley N. S., Liu H., Salpeter E. E. The cost-effectiveness of hormone therapy in younger and older postmenopausal women. Am J Med: 2009; 122 1 42 52, e2
136. Shumaker S. A., Legault C., Kuller L., et al. Women's Health Initiative Memory Study Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA: 2004; 291 24 2947 2958 (Pubitemid 38802684)
137. Coker L. H., Espeland M. A., Rapp S. R., et al. Postmenopausal hormone therapy and cognitive outcomes: the Women's Health Initiative Memory Study (WHIMS). J Steroid Biochem Mol Biol: 2010; 118 4-5 304 310
138. Berent-Spillson A., Persad C. C., Love T., et al. Hormonal environment affects cognition independent of age during the menopause transition. J Clin Endocrinol Metab: 2012; 97 9 E1686 E1694
139. Cohen L. S., Soares C. N., Vitonis A. F., Otto M. W., Harlow B. L. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry: 2006; 63 4 385 390
140. Freeman E. W., Sammel M. D., Lin H., Nelson D. B. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry: 2006; 63 4 375 382
141. Greendale G. A., Huang M. H., Wight R. G., et al. Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology: 2009; 72 21 1850 1857
142. Schmidt P. J., Nieman L., Danaceau M. A., et al. Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol: 2000; 183 2 414 420 (Pubitemid 30651090)
143. Soares C. N., Almeida O. P., Joffe H., Cohen L. S. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry: 2001; 58 6 529 534 (Pubitemid 32523731)
144. Morrison M. F., Kallan M. J., Ten Have T., Katz I., Tweedy K., Battistini M. Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry: 2004; 55 4 406 412 (Pubitemid 38199991)
145. Weber M., Mapstone M. Memory complaints and memory performance in the menopausal transition. Menopause: 2009; 16 4 694 700
146. McEwen B. S. Invited review: Estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol: 2001; 91 6 2785 2801 (Pubitemid 33108046)
147. Deecher D., Andree T. H., Sloan D., Schechter L. E. From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes. Psychoneuroendocrinology: 2008; 33 1 3 17
148. Eriksson O., Landén M., Sundblad C., Holte J., Eriksson E., Naessén T. Ovarian morphology in premenstrual dysphoria. Psychoneuroendocrinology: 2012; 37 6 742 751
149. Becker D., Orr A., Weizman A., Kotler M., Pines A. Depressed mood through women's reproductive cycle: correlation to mood at menopause. Climacteric: 2007; 10 1 46 50 (Pubitemid 46277797)
150. Bhagat M., Mukherjee S., De P., et al. Clustering of cardiometabolic risk factors in Asian Indian women: Santiniketan women study. Menopause: 2010; 17 2 359 364
151. Bleil M. E., Adler N. E., Pasch L. A., et al. Depressive symptomatology, psychological stress, and ovarian reserve: a role for psychological factors in ovarian aging? Menopause: 2012; 19 11 1176 1185
152. Bleil M. E., Adler N. E., Pasch L. A., et al. Psychological stress and reproductive aging among pre-menopausal women. Hum Reprod: 2012; 27 9 2720 2728